BRIEF-Sanofi: rolling reviews of COVID-19 recombinant vaccine to start soon in UK, Canada and Singapore

BRIEF-Sanofi: rolling reviews of COVID-19 recombinant vaccine to start soon in UK, Canada and Singapore

Sanofi: * SANOFI SAYS 'ROLLING REVIEWS" OF ITS COVID-19 RECOMBINANT VACCINE ARE ABOUT TO START IN BRITAIN, CANADA AND SINGAPORE IN THE "COMING DAYS"

* SANOFI SAYS "ROLLING REVIEW" OF ITS COVID-19 RECOMBINANT VACCINE IS ALSO EXPECTED BY THE WORLD HEALTH ORGANIZATION * Sanofi made the comments in a statement Emailed to Reuters

* Europe's drug regulator said on Tuesday it had started a real-time review of the COVID-19 vaccine developed by French drugmaker Sanofi SASY.PA and Britain's GlaxoSmithKline GSK.L, the fifth shot under such a review currently.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.